IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
University of Pittsburgh
University of Chicago
Genmab
Fate Therapeutics
NRG Oncology
NRG Oncology
University of Chicago
Memorial Sloan Kettering Cancer Center
University of Chicago
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
Fulgent Pharma LLC.
Hoffmann-La Roche
Eastern Cooperative Oncology Group
University of Chicago
Neonc Technologies, Inc.
Gilead Sciences
Ohio State University Comprehensive Cancer Center
National Medical Research Radiological Centre of the Ministry of Health of Russia
University of Chicago
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Brown University
Inhibrx Biosciences, Inc
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Adlai Nortye Biopharma Co., Ltd.
Rakuten Medical, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
University of Southern California
Hoffmann-La Roche
Nurix Therapeutics, Inc.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Merck Sharp & Dohme LLC
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
invoX Pharma Limited
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Iovance Biotherapeutics, Inc.
Merck Sharp & Dohme LLC
Akeso